This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)

What this study is about

The goal of this study is to learn whether early referral to palliative care improves quality of life for patients with advanced sarcoma. Participants enrolled in this study will complete quality of life questionnaires before starting their treatment, and every 6 weeks for 24 weeks.

Who can join (things the study team will check)

✅ You may be able to join if…

• Signed written and voluntary informed consent.
• Have histologically documented advanced sarcoma, either locally advanced not amenable to curative treatment, or metastatic.
• Age ≥ 18 years.
• Have not received any previous systemic treatment with palliative intent for advanced sarcoma.
• Performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale.
• Life expectancy > 6 months.
• Willing/able to complete questionnaires.

🚫 You may not be able to join if…

• Clinical evidence of cognitive impairment that would preclude the ability to provide informed consent and complete questionnaires, at investigator´s discretion.
• Patient in need of urgent home support services or symptom management through a palliative care team.
• Patient is being actively followed by a palliative care physician.
• Active psychiatric disorder or drug abuse.
• Insufficient English literacy to complete questionnaires.

Where this trial is running

• Mount Sinai Hospital, Toronto, Ontario, Canada

Who to contact

Clinical Trials Manager · 416-586-8440 · Oncology.Research@sinaihealth.ca

It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT06805669.